Navigation Links
A novel marker of colorectal carcinoma
Date:5/22/2009

The colorectal cancer is thought to be resulted from a combination of environmental factors, diet, lifestyle, chronic inflammation and accumulation of specific genetic alterations. The pathogenesis and development of colorectal cancer involve multi-genes and multi-steps. TSPAN1 (GenBank Accession No. AF065388) is a new member of TM4SF located at chromosome 1 p34.1. It encodes a 241 amino acid protein. TSPAN1 was reported as a tumor-related gene recently.

A research team led by Dr Jian-Wei Zhu from Nantong University, China, investigated the association between TSPAN1 and human colorectal adenocarcinoma. Their study will be published on May 14, 2009 in the World Journal of Gastroenterology

In this study, total RNA was extracted in 20 human adenocarcinoma tissues for TSPAN1 mRNA assay by RT-PCR. Eighty-eight specimens of human colorectal adenocarcinoma were surgically removed. TSPAN1 protein levels in cancer tissues were determined by immunohistochemistry using a polyclonal antibody against self-prepared TSPAN1. The correlation between TSPAN1 expression and the clinicopathological factors and the overall survival rate was analyzed by univariate and multivariate assay.

By RT-PCR assay, it was shown that TSPAN1 mRNA was detected in 90.0% (18/20) of cancerous tissue. The light density of TSPAN1 mRNA expression levels was 0.89 0.30 in adenocarcinoma by gel-image system. TSPAN1 protein expression was detected in 78.41 %( 69/88) and weakly expressed in 40% normal colorectal tissues by immunohistochemistry. There were significant differences between colorectal adenocarcinoma and normal control epithelium (P < 0.05). TSPAN1 protein expression in colorectal cancerous tissue was significantly correlated with the histological grade, cell expression PCNA, lymph nodal metastasis and TNM staging of the disease. Patients with TSPAN1 protein over expression had a significantly shorter survival period than that in patients with TSPAN1 protein negative or weak expression, respectively (P<0.05). Furthermore, by multivariate analysis TSPAN1 protein expression demonstrated an independent prognostic factor for human colorectal cancers (P<0.05, relative risk 0.755; 95% confidence interval 0.302-1.208).

The result indicated that testing TSPAN1 expression in tissues would be a useful tool to evaluate the prognosis of patients with colorectal cancer.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
3. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
4. Novel Cooling Therapy May Have Aided Injured Football Player
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 ... Foundation the US Special Operations Command’s Patriot Award. The award was presented by ... Task Force Dagger Foundation for its significant and enduring support to the command. ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
(Date:3/23/2017)... ... 2017 , ... “The Trainer”: an electrifying and suspenseful gunslinger novel with ... with an active imagination and an enthusiasm for action and adventure stories. ... Bill Hart, who sat looking at the thirty-three notches that lined the edges of ...
(Date:3/22/2017)... , ... March 23, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... Asia Convention, currently taking place at the Suntec Singapore International Exhibition & Convention ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... consuming and frustrating and this tool bypasses that. Healthcare facilities across the ... an opportunity to offer their clients and hospitals, across the country, an efficient ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 BioLineRx Ltd. ... immunology, announced today that it has acquired Agalimmune Ltd., a ... consideration consisted of a $6 million upfront payment, of which ... shares. Additional future payments may be made based on development ... ...
(Date:3/23/2017)... March 23, 2017 AbbVie, a global biopharmaceutical ... choreographer Julianne Hough is helping to raise ... the Know about ME in EndoMEtriosis . "   ... women to learn about and understand endometriosis, a disease ... and to address their symptoms with a healthcare professional. ...
(Date:3/23/2017)... , March 23, 2017 ... in Brussels , My UV ... bad sun habits into life-saving ones, was awarded ... (AIM). Launched in 2016, the "Nudging for Good" ... easy and desirable for people to change behaviour ...
Breaking Medicine Technology: